Personalized approach: Carbiotix ramps up rare disease therapeutics development as latest funding round closes

As the company’s latest fund round closes, the total funds raised to date are €1m over four years

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

12 Apr 2019 --- Swiss biotech company Gnubiotics is launching GNU100 – an oligosaccharide and glycopeptide mix – touted as “the first microbiome specialty... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Apr 2019 --- Replacing red meat with healthy plant proteins may be a running start to slashing the risk factors for cardiovascular disease (CVD). This is according to... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

11 Apr 2019 ---  Tata Chemicals Ltd and Brenntag Food & Nutrition, a business unit of the Brenntag Group in North America, have announced an agreement for the distribution... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 Apr 2019 --- Probiotics, often called “good” or “helpful” bacteria and yeast that live in the stomach, play an essential role in digestive processes... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 Apr 2019 --- Dietary fiber may shield against lung diseases, such as chronic obstructive pulmonary disease (COPD), as it boosts the production of anti-inflammatory short-chain... Read More